ExodusPoint Capital Management’s Vaxart VXRT Stock Holding History

ExodusPoint Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-78,439	Closed	-$102K	–	2023
2024 Q1	$102K	Buy	+78,439	New	+$82.2K	﹤0.01%	1412
2023 Q1	–	Sell	-103,363	Closed	-$99K	–	2164
2022 Q4	$99K	Sell	103,363 -315,300	-75%	-$446K	﹤0.01%	1519
2022 Q3	$913K	Buy	418,663 +360,378	+618%	+$1.24M	0.01%	1148
2022 Q2	$204K	Buy	+58,285	New	+$218K	﹤0.01%	1655
2021 Q4	–	Sell	-43,600	Closed	-$347K	–	2637
2021 Q3	$347K	Buy	+43,600	New	+$359K	﹤0.01%	1557
2020 Q4	–	Sell	-25,405	Closed	-$169K	–	2416
2020 Q3	$169K	Buy	+25,405	New	+$226K	﹤0.01%	1518
2020 Q2	–	Sell	-16,100	Closed	-$28K	–	2063
2020 Q1	$28K	Buy	+16,100	New	+$20.5K	﹤0.01%	995

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's VXRT Position: Q2 2024 in Review

ExodusPoint Capital Management sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 78,439 shares — an estimated $102K sold.

ExodusPoint Capital Management first reported a position in VXRT in Q1 2020 and held it in 7 quarters. The position peaked at $913K in Q3 2022. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

ExodusPoint Capital Management reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 78,439 Vaxart shares in Q2 2024, an estimated $102K.
ExodusPoint Capital Management first reported a position in Vaxart in Q1 2020 and held it in 7 quarters.
ExodusPoint Capital Management's Vaxart position peaked at $913K in Q3 2022.
100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.